KIORA PHARMACEUTICALS, INC. Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
KIORA PHARMACEUTICALS, INC. (KPRX) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $5 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2025 was $2.37K, a 47.53% decline from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2024 was $4.52K.
- KIORA PHARMACEUTICALS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2023 was $0.00.
| Period end | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|---|
| 2026-06-30 | $5.00 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $2.37K 10-K · filed 2026-03-25 | |
| 2025-06-30 | $1.76K 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $4.52K 10-K · filed 2026-03-25 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |